Search Results | Diabetes | American Diabetes Association

1-20 of 99

2 3 4 5

Sort by

Sort Order Select

Meeting Abstracts

9-OR: ADA Presidents' Select Abstract: m6A mRNA Methylation Regulates the Innate Immune Response in Human Beta Cells

DARIO F. DE JESUS, ZIJIE ZHANG, NATALIE K. BROWN, GIORGIO BASILE, LING XIAO, SEVIM KAHRAMAN, CLAYTON E. MATHEWS, ALVIN C. POWERS, MARK A. ATKINSON, DECIO L. EIZIRIK, ROHIT KULKARNI

Diabetes 2022;71(Supplement_1):9-OR

DOI: https://doi.org/10.2337/db22-9-OR

Published: 01 June 2022

View article

Meeting Abstracts

63-OR: A Model-Based Clinical Trial Simulation Tool to Optimize Clinical Trial Designs for Type 1 Diabetes Prevention Studies

JUAN F. MORALES, RHODA MUSE, JAGDEEP PODICHETTY, JACKSON BURTON, SARAH DAVID, FRANCIS MARTIN, MARK A. ATKINSON, MICHAEL J. HALLER, MARTHA CAMPBELL-THOMPSON, KLAUS ROMERO, INISH O'DOHERTY, STEPHAN SCHMIDT, SARAH KIM

Diabetes 2022;71(Supplement_1):63-OR

DOI: https://doi.org/10.2337/db22-63-OR

Published: 01 June 2022

View article

Meeting Abstracts

1229-P: Participation of Hispanic (Hisp) and African-American (AA) Youth in an Observational Study in Diabetes

MARIA J. REDONDO, MUSTAFA TOSUR, SERIFE UYSAL, ANDREW B. MUIR, SANIA IFTEKHAR, SAIMA DEEN, DANIEL J. PERRY, KYLIE K. HARRALL, DEBORAH H. GLUECK, KENDRA VEHIK, RICHARD A. ORAM, WILLIAM HAGOPIAN, DANA DABELEA, MARK A. ATKINSON, RACE (DISCOVER) DIABETES STUDY IN CHILDREN OF DIVERSE ETHNICITY

Diabetes 2022;71(Supplement_1):1229-P

DOI: https://doi.org/10.2337/db22-1229-P

Published: 01 June 2022

View article

Meeting Abstracts

296-OR: Single-Cell Multiomic Analysis of the Human Pancreas in Type 1 Diabetes

REBECCA MELTON, ELISHA BEEBE, CHUN ZENG, MICHAEL T. MILLER, GAOWEI WANG, CAROLYN MCGRAIL, HANNAH MUMMEY, IRINA KUSMARTSEVA, MARK A. ATKINSON, SEBASTIAN PREISSL, MAIKE SANDER, KYLE J. GAULTON

Diabetes 2022;71(Supplement_1):296-OR

DOI: https://doi.org/10.2337/db22-296-OR

Published: 01 June 2022

View article

Meeting Abstracts

825-P: Composite Glucose and C-Peptide Endpoints Show Early Efficacy in Recent-Onset Type 1 Diabetes (T1D) Clinical Trials

LAURA M. JACOBSEN, DAVID D. CUTHBERTSON, MICHAEL J. HALLER, HEBA M. ISMAIL, EMILY K. SIMS, STEPHEN E. GITELMAN, DIANE K. WHERRETT, ANTOINETTE MORAN, MARK A. ATKINSON, ALBERTO PUGLIESE, PETER GOTTLIEB, JAY SOSENKO

Diabetes 2022;71(Supplement_1):825-P

DOI: https://doi.org/10.2337/db22-825-P

Published: 01 June 2022

View article

Meeting Abstracts

187-OR: Declines in ß-Cell Glucose Responsiveness Correlate with Loss of Glucose Metabolism during T1D Pathogenesis

MOLLIE HUBER, MARJAN SLAK RUPNIK, DENISE M. DROTAR, HELMUT HILLER, SR., MARIA BEERY, IRINA KUSMARTSEVA, MARK A. ATKINSON, EDWARD PHELPS, CLAYTON E. MATHEWS

Diabetes 2022;71(Supplement_1):187-OR

DOI: https://doi.org/10.2337/db22-187-OR

Published: 01 June 2022

View article

Meeting Abstracts

11-OR: Transcriptome Heterogeneity in Insulin-Positive Insulitic vs. Noninsulitic Human Islets in Type 1 Diabetes (T1D)

ALYSSA M. DYE, GRACE ASHBERY, NATALIYA I. LENCHIK, MARK A. ATKINSON, CLAYTON E. MATHEWS, MARTHA CAMPBELL-THOMPSON, IVAN C. GERLING

Diabetes 2022;71(Supplement_1):11-OR

DOI: https://doi.org/10.2337/db22-11-OR

Published: 01 June 2022

View article

Meeting Abstracts

1024-P: Identification of Sex-Specific Cytokine and Viral Infection Profiles in Type 1 Diabetes Patients

KHYATI GIRDHAR, ALEJANDRA PINA, JELENA MOMIROV, MARK A. ATKINSON, JASON LADNER, EMRAH ALTINDIS

Diabetes 2022;71(Supplement_1):1024-P

DOI: https://doi.org/10.2337/db22-1024-P

Published: 01 June 2022

View article

Meeting Abstracts

1262-P: Developing a Computable Phenotype Algorithm for Identification of Children and Adolescents with Diabetes Using Electronic Health Records

Diabetes 2022;71(Supplement_1):1262-P

DOI: https://doi.org/10.2337/db22-1262-P

Published: 01 June 2022

View article

Meeting Abstracts

350-OR: The Oral Disposition Index (ODI) Predicts Type 1 Diabetes (T1D) in Autoantibody-Positive (Ab+) Individuals

HEBA M. ISMAIL, DAVID D. CUTHBERTSON, MARIA J. REDONDO, LAURA M. JACOBSEN, MARK A. ATKINSON, JAY SOSENKO, DIABETES PREVENTION TRIAL TYPE 1, TYPE 1 DIABETES TRIALNET

Diabetes 2022;71(Supplement_1):350-OR

DOI: https://doi.org/10.2337/db22-350-OR

Published: 01 June 2022

View article

Meeting Abstracts

1257-P: Associations of Five-Year Type 1 Diabetes (T1D) Risk with Predictors Using Cross-Sample Validation

HEBA M. ISMAIL, DAVID D. CUTHBERTSON, MARK A. ATKINSON, MARIA J. REDONDO, JAY SOSENKO, TYPE 1 DIABETES TRIALNET

Diabetes 2022;71(Supplement_1):1257-P

DOI: https://doi.org/10.2337/db22-1257-P

Published: 01 June 2022

View article

Meeting Abstracts

253-LB: Ethnic Differences in Pancreatic Hormone Secretion in Health and T2D

NICOLAI M. DOLIBA, JEFFREY ROMAN, ANDREA V. ROZO, WEI QIN, CHENGYANG LIU, ALI NAJI, MICHAEL R. RICKELS, MARK A. ATKINSON, ALVIN C. POWERS, MARCELA BRISSOVA, KLAUS H. KAESTNER, DORIS A. STOFFERS

Diabetes 2022;71(Supplement_1):253-LB

DOI: https://doi.org/10.2337/db22-253-LB

Published: 01 June 2022

View article

Journal Articles

Erratum. The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes 2021;70:1623–1633

Jessica L. Dunne, Jennifer L. Maizel, Amanda L. Posgai, Mark A. Atkinson, Linda A. DiMeglio

Diabetes 2022;71(6):1371

DOI: https://doi.org/10.2337/db22-er06a

Published: 05 March 2022

View article

Journal Articles

The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence

Jessica L. Dunne, Jennifer L. Maizel, Amanda L. Posgai, Mark A. Atkinson, Linda A. DiMeglio

Diabetes 2021;70(8):1623–1633

DOI: https://doi.org/10.2337/db21-0052

Published: 15 June 2021

View article

Meeting Abstracts

246-OR: Probing the Role of Alternative Splicing of IKZF1 in Risk for Type 1 Diabetes

LUCIA PASTOR PALOMO, JEREMY R.B. NEWMAN, MARK A. ATKINSON, PATRICK J. CONCANNON

Diabetes 2021;70(Supplement_1):246-OR

DOI: https://doi.org/10.2337/db21-246-OR

Published: 01 June 2021

View article

Meeting Abstracts

287-OR: M6A mRNA Methylation Regulates the Innate Immune Response in Human ß-Cells

DARIO F. DE JESUS, ZIJIE ZHANG, NATALIE K. BROWN, JIANG HU, SEVIM KAHRAMAN, CLAYTON E. MATHEWS, ALVIN C. POWERS, MARK A. ATKINSON, DECIO L. EIZIRIK, CHUAN HE, ROHIT KULKARNI

Diabetes 2021;70(Supplement_1):287-OR

DOI: https://doi.org/10.2337/db21-287-OR

Published: 01 June 2021

View article

Meeting Abstracts

75-OR: Marked Heterogeneity in Nondiabetic, Autoantibody-Positive (Ab+) Individuals with Dysglycemia: Implications for Type 1 Diabetes (T1D) Staging

MARIA J. REDONDO, DAVID D. CUTHBERTSON, BRANDON M. NATHAN, EMILY K. SIMS, MUSTAFA TOSUR, INGRID LIBMAN, JAY S. SKYLER, CARMELLA EVANS-MOLINA, MARK A. ATKINSON, JAY SOSENKO

Diabetes 2021;70(Supplement_1):75-OR

DOI: https://doi.org/10.2337/db21-75-OR

Published: 01 June 2021

View article

Meeting Abstracts

1117-P: Characterizing Glucose/C-Peptide Response Curve (GCRC) Phenotypes to Enhance Selection Specificity for Type 1 Diabetes (T1D) Prevention Trials

HEBA M. ISMAIL, DAVID D. CUTHBERTSON, MARIA J. REDONDO, CARMELLA EVANS-MOLINA, ANDREA STECK, HENRY RODRIGUEZ, STEPHEN E. GITELMAN, KEVAN C. HEROLD, JAY S. SKYLER, BRANDON M. NATHAN, MARK A. ATKINSON, LINDA DIMEGLIO, JAY SOSENKO

Diabetes 2021;70(Supplement_1):1117-P

DOI: https://doi.org/10.2337/db21-1117-P

Published: 01 June 2021

View article

Meeting Abstracts

589-P: Effect of Oral Insulin (OI) on Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes (T1D)

LAURA M. JACOBSEN, DAVID D. CUTHBERTSON, EMILY K. SIMS, HEBA M. ISMAIL, LINDA DIMEGLIO, TAYLOR M. TRIOLO, MARIA J. REDONDO, MARKUS LUNDGREN, PETER GOTTLIEB, MARK A. ATKINSON, JEFFREY KRISCHER, DESMOND SCHATZ, JAY SOSENKO

Diabetes 2021;70(Supplement_1):589-P

DOI: https://doi.org/10.2337/db21-589-P

Published: 01 June 2021

View article

Meeting Abstracts

938-P: A Human Gut Commensal, Parabacteroides Distasonis, Enhances Type 1 Diabetes Autoimmunity via Molecular Mimicry

KHYATI GIRDHAR, QIAN HUANG, I-TING CHOW, CLAUDIA BRADY, AMOL RAISINGANI, TU TRAN, WILLIAM KWOK, MARK A. ATKINSON, C. RONALD KAHN, EMRAH ALTINDIS

Diabetes 2021;70(Supplement_1):938-P

DOI: https://doi.org/10.2337/db21-938-P

Published: 01 June 2021

View article

2 3 4 5

NARROW

9-OR: ADA Presidents' Select Abstract: m6A mRNA Methylation Regulates the Innate Immune Response in Human Beta Cells

63-OR: A Model-Based Clinical Trial Simulation Tool to Optimize Clinical Trial Designs for Type 1 Diabetes Prevention Studies

1229-P: Participation of Hispanic (Hisp) and African-American (AA) Youth in an Observational Study in Diabetes

296-OR: Single-Cell Multiomic Analysis of the Human Pancreas in Type 1 Diabetes

825-P: Composite Glucose and C-Peptide Endpoints Show Early Efficacy in Recent-Onset Type 1 Diabetes (T1D) Clinical Trials

187-OR: Declines in ß-Cell Glucose Responsiveness Correlate with Loss of Glucose Metabolism during T1D Pathogenesis

11-OR: Transcriptome Heterogeneity in Insulin-Positive Insulitic vs. Noninsulitic Human Islets in Type 1 Diabetes (T1D)

1024-P: Identification of Sex-Specific Cytokine and Viral Infection Profiles in Type 1 Diabetes Patients

1262-P: Developing a Computable Phenotype Algorithm for Identification of Children and Adolescents with Diabetes Using Electronic Health Records

350-OR: The Oral Disposition Index (ODI) Predicts Type 1 Diabetes (T1D) in Autoantibody-Positive (Ab+) Individuals

1257-P: Associations of Five-Year Type 1 Diabetes (T1D) Risk with Predictors Using Cross-Sample Validation

253-LB: Ethnic Differences in Pancreatic Hormone Secretion in Health and T2D

Erratum. The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes 2021;70:1623–1633

The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence

246-OR: Probing the Role of Alternative Splicing of IKZF1 in Risk for Type 1 Diabetes

287-OR: M6A mRNA Methylation Regulates the Innate Immune Response in Human ß-Cells

75-OR: Marked Heterogeneity in Nondiabetic, Autoantibody-Positive (Ab+) Individuals with Dysglycemia: Implications for Type 1 Diabetes (T1D) Staging

1117-P: Characterizing Glucose/C-Peptide Response Curve (GCRC) Phenotypes to Enhance Selection Specificity for Type 1 Diabetes (T1D) Prevention Trials

589-P: Effect of Oral Insulin (OI) on Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes (T1D)

938-P: A Human Gut Commensal, Parabacteroides Distasonis, Enhances Type 1 Diabetes Autoimmunity via Molecular Mimicry

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only